During the activation of these cells, S100A8/S100A9 complexes are locally released in virtually all inflammatory disorders that are associated with phagocyte activation, like autoimmune diseases, rheumatoid arthritis, allergies, cardiovascular diseases, or local and systemic infections and tumours7, whereas virtually no expression can be found in healthy tissue. Here, S100A9 is linked to autoimmune disease.